The other side of the Maillard reaction

Annals of the New York Academy of Sciences

Volumn 1126, Issue , 2008, Pages 107-112

  Nagaraj, Ram H ^a   Biswas, Ashis ^a,b   Miller, Antonia ^a,c   Oya Ito, Tomoko ^a,d   Bhat, Manjunatha ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c MONASH UNIVERSITY   (Australia)

^d KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Argpyrimidine; Chaperone function; Hydroimidazolone; Methylglyoxal; crystallin

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALANINE; ALPHA CRYSTALLIN; ARGININE; ASCORBIC ACID; CHAPERONE; IMIDAZOLE DERIVATIVE; METHYLGLYOXAL; PYRIMIDINE; RIBOSE;

AGING; CATARACT; CHEMICAL MODIFICATION; CONFERENCE PAPER; GLYCATION; LENS; MUTATION; PROTEIN FUNCTION;

EID: 42549161831     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1433.045     Document Type: Conference Paper

References (29)

1. 1 Sun, Y. & T.H. MacRae. 2005. Small heat shock proteins: molecular structure and chaperone function. Cell. Mol. Life Sci. 62: 2460–2476.
2. 2 Andley, U.P. 2007. Crystallins in the eye: function and pathology. Prog. Retin Eye Res. 26: 78–98.
3. 3 Sharma, K.K., H. Kaur & K. Kester. 1997. Functional elements in molecular chaperone alpha‐crystallin: identification of binding sites in alpha B‐crystallin. Biochem. Biophys. Res. Commun. 239: 217–222.
4. 4 Sharma, K.K. et al. 2000. Synthesis and characterization of a peptide identified as a functional element in alphaA‐crystallin. J. Biol. Chem. 275: 3767–3771.
5. 5 Ghosh, J.G., M.R. Estrada & J.I. Clark. 2005. Interactive domains for chaperone activity in the small heat shock protein, human alphaB crystallin. Biochemistry 44: 14854–14869.
6. 6 Hsu, C.D., S. Kymes & J.M. Petrash. 2006. A transgenic mouse model for human autosomal dominant cataract. Invest. Ophthalmol. Vis. Sci. 47: 2036–2044.
7. 7 Brady, J.P. et al. 1997. Targeted disruption of the mouse alpha A‐crystallin gene induces cataract and cytoplasmic inclusion bodies containing the small heat shock protein alpha B‐crystallin. Proc. Natl. Acad. Sci. USA 94: 884–889.
8. 8 Boyle, D.L. et al. 2003. Morphological characterization of the Alpha A‐ and Alpha B‐crystallin double knockout mouse lens. BMC Ophthalmol. 3: 3.
9. 9 Sun, Y. & T.H. MacRae. 2005. The small heat shock proteins and their role in human disease. FEBS J. 272: 2613–2627.
10. 10 Ousman, S.S. et al. 2007. Protective and therapeutic role for alphaB‐crystallin in autoimmune demyelination. Nature 448: 474–479.
11. 11 Ahmed, N. & P.J. Thornalley. 2007. Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes. Metab. 9: 233–245.
12. 12 Peppa, M. & H. Vlassara. 2005. Advanced glycation end products and diabetic complications: a general overview. Hormones (Athens). 4: 28–37.
13. 13 Stitt, A.W. 2005. The maillard reaction in eye diseases. Ann. N.Y. Acad. Sci. 1043: 582–597.
14. 14 Cheng, R. et al. 2005. K2P–a novel cross‐link from human lens protein. Ann. N.Y. Acad. Sci. 1043: 184–194.
15. 15 Argirov, O.K., B. Lin & B.J. Ortwerth. 2004. 2‐ammonio‐6‐(3‐oxidopyridinium‐1‐yl)hexanoate (OP‐lysine) is a newly identified advanced glycation end product in cataractous and aged human lenses. J. Biol. Chem. 279: 6487–6495.
16. 16 Nagaraj, R.H. et al. 1991. High correlation between pentosidine protein crosslinks and pigmentation implicates ascorbate oxidation in human lens senescence and cataractogenesis. Proc. Natl. Acad. Sci. USA 88: 10257–10261.
17. 17 Nagaraj, R.H. & C. Sady. 1996. The presence of a glucose‐derived Maillard reaction product in the human lens. FEBS Lett. 382: 234–238.
18. 18 Wilker, S.C. et al. 2001. Chromatographic quantification of argpyrimidine, a methylglyoxal‐derived product in tissue proteins: comparison with pentosidine. Anal. Biochem. 290: 353–358.
19. 19 Ahmed, M.U. et al. 1997. N‐epsilon‐(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J. 324: 565–570.
20. 20 Frye, E.B. et al. 1998. Role of the Maillard reaction in aging of tissue proteins. Advanced glycation end product‐dependent increase in imidazolium cross‐links in human lens proteins. J. Biol. Chem. 273: 18714–18719.
21. 21 Ahmed, N. et al. 2003. Methylglyoxal‐derived hydroimidazolone advanced glycation end‐products of human lens proteins. Invest. Ophthalmol. Vis. Sci. 44: 5287–5292.
22. 22 Cherian, M. & E.C. Abraham. 1995. Decreased molecular chaperone property of alpha‐crystallins due to posttranslational modifications. Biochem. Biophys. Res. Commun. 208: 675–679.
23. 23 Van Boekel, M.A. et al. 1996. The influence of some post‐translational modifications on the chaperone‐like activity of alpha‐crystallin. Ophthalmic Res. 28 Suppl. 1: 32–38.
24. 24 Nagaraj, R.H. et al. 2003. Enhancement of chaperone function of alpha‐crystallin by methylglyoxal modification. Biochemistry 42: 10746–10755.
25. 25 Das, K.P. & W.K. Surewicz. 1995 Temperature‐induced exposure of hydrophobic surfaces and its effect on the chaperone activity of alpha‐crystallin. FEBS Lett. 369: 321–325.
26. 26 Raman, B., T. Ramakrishna & C.M. Rao. 1995. Temperature dependent chaperone‐like activity of alpha‐crystallin. FEBS Lett. 365: 133–136.
27. 27 Biswas, A. et al. 2006. Effect of site‐directed mutagenesis of methylglyoxal‐modifiable arginine residues on the structure and chaperone function of human alphaA‐crystallin. Biochemistry 45: 4569–4577.
28. 28 Puttaiah, S. et al. 2007. Methylglyoxal inhibits glycation‐mediated loss in chaperone function and synthesis of pentosidine in alpha‐crystallin. Exp. Eye Res. 84: 914–921.
29. 29 Monnier, V.M., D.R. Sell & S. Genuth. 2005. Glycation products as markers and predictors of the progression of diabetic complications. Ann. N.Y. Acad. Sci. 1043: 567–581.